News
A team of researchers from the Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) has demonstrated that combining advanced genomic techniques with the use of combination antiviral therapies can eliminate persistent COVID in immunocompromised patients, marking a significant advance in the clinical management of these complex cases.
You can now register for the 13th Research and Innovation Conference of the Gregorio Marañón Health Research Institute
A team of researchers from the Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) has demonstrated that combining advanced genomic techniques with the use of combination antiviral therapies can eliminate persistent COVID in immunocompromised patients, marking a significant advance in the clinical management of these complex cases.
The ISCIII call for the IMPaCT Precision Medicine Infrastructure has been approved
On July 28, the Council of Ministers approved the ISCIII call for proposals for IMPaCT.
Its objective is to consolidate the Precision Medicine infrastructure in the National Health System through three fundamental pillars.
Resolution of the IiSGM Scientific Photography Contest 2026_Fourth Edition
The photograph Under the Sea, by Marta Puerto Cantero (Hepatology and Gastroenterology Laboratory, group 7.02), has been selected as the winner of the 4th Edition of the IiSGM Scientific Photography Competition and will be featured on the cover of the 2025 Scientific Report.
The IiSGM opens its doors to fourth-year compulsory secondary education students to foster scientific vocations
Students have been able to gain practical insight into the biomedical research environment by becoming part of the day-to-day activities of several research groups as part of the 4th ESO+Company Programme.
A study led by IiSGM concludes that flu vaccination reduces severe heart attacks and pulmonary blood clots in critically ill cardiac patients
The multicenter study analyzed nearly 400 patients admitted to cardiac intensive care units.
IiSGM researchers advance the preclinical development of a neuroprotective eye drop for the treatment of glaucoma
The project stems from a research line at the Renal Pathophysiology Laboratory of the IiSGM and progresses towards its clinical application through Telara Pharma, a spin-off of the Institute.
The Orthopedic Surgery and Traumatology Department of Hospital Gregorio Marañón celebrates 75 years of research, innovation and knowledge transfer
On the occasion of reaching this milestone, their contribution to generating knowledge and developing new solutions for musculoskeletal disorders is highlighted.
The IiSGM completes the world's first clinical trial with thyTreg cells in pediatric heart transplantation
The IiSGM Immunoregulation Laboratory has been developing, together with the Pediatric Cardiology Department and specialists in Pediatric Cardiac Surgery, a pioneering strategy that opens up a new avenue for preventing rejection.
An IiSGM study combining genomics and antiviral therapy opens up new avenues for tackling persistent COVID in immunocompromised patients
The study highlights that whole-genome sequencing of SARS-CoV-2 has become a key tool for improving diagnosis and guiding personalised treatments, especially in patients with onco-haematological diseases.